NovaDigm Therapeutics Announces Initiation of Phase 2a Clinical Trial of NDV-3A in Staphylococcus aureus Read more
PhoenixMD Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND Read more
FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Read more
Sandoz and Pear Therapeutics to develop and commercialize prescription digital therapeutics Read more
Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes Read more